Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
Abstract. While classical nodal mantle cell lymphoma (cMCL) is often associated with involvement of multiple extranodal sites, isolated extranodal disease (ED) at the time of diagnosis is a rare event; data on the outcome of these forms are lacking. On behalf of the European MCL Network, we conducte...
Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2020-02-01
|
Seri Bilgileri: | HemaSphere |
Online Erişim: | http://journals.lww.com/10.1097/HS9.0000000000000302 |
_version_ | 1827332341780971520 |
---|---|
author | Lucia Morello Sara Rattotti Laura Giordano Mats Jerkeman Tom van Meerten Katarzyna Krawczyk Filipa Moita Dario Marino Simone Ferrero Michał Szymczyk Igor Aurer Tarec Christoffer El-Galaly Alice Di Rocco Carlo Visco Giuseppe Carli Irene Defrancesco Carmelo Carlo-Stella Martin Dreyling Armando Santoro Luca Arcaini |
author_facet | Lucia Morello Sara Rattotti Laura Giordano Mats Jerkeman Tom van Meerten Katarzyna Krawczyk Filipa Moita Dario Marino Simone Ferrero Michał Szymczyk Igor Aurer Tarec Christoffer El-Galaly Alice Di Rocco Carlo Visco Giuseppe Carli Irene Defrancesco Carmelo Carlo-Stella Martin Dreyling Armando Santoro Luca Arcaini |
author_sort | Lucia Morello |
collection | DOAJ |
description | Abstract. While classical nodal mantle cell lymphoma (cMCL) is often associated with involvement of multiple extranodal sites, isolated extranodal disease (ED) at the time of diagnosis is a rare event; data on the outcome of these forms are lacking. On behalf of the European MCL Network, we conducted a retrospective analysis on the clinical characteristics and outcomes of MCL presenting with isolated or predominant ED (MALT MCL). We collected data on 127 patients with MALT MCL diagnosed from 1998 to 2015: 78 patients (61%) were male with a median age of 65 years. The involved sites include: upper airways + Waldeyer ring (40; 32%), gastrointestinal tract (32; 25%), ocular adnexa (17; 13%), oral cavity and salivary glands (17; 13%) and others (13; 1%); 7 patients showed multiple extranodal sites. The median follow-up was 80 months (range: 6–182), 5-year progression-free survival (PFS) was 45% (95% CI: 35–54) and 5-year overall survival (OS) was 71% (95% CI: 62–79). In an explorative setting, we compared MALT MCL with a group of 128 cMCL patients: MALT MCL patients showed a significantly longer PFS and OS compared with nodal cMCL; with a median PFS of 4.5 years vs 2.8 years (p = 0.001) and median OS of 9.8 years vs 6.9 years (p = 0.018), respectively. Patients with MALT MCL at diagnosis showed a more favorable prognosis and indolent course than classical nodal type. This clinical variant of MCL should be acknowledged to avoid possible over-treatment. |
first_indexed | 2024-03-07T16:57:37Z |
format | Article |
id | doaj.art-fb8c812f5824478d951c96f41921e02a |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:57:37Z |
publishDate | 2020-02-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-fb8c812f5824478d951c96f41921e02a2024-03-03T03:54:52ZengWileyHemaSphere2572-92412020-02-0141e30210.1097/HS9.0000000000000302202002000-00011Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia MorelloSara RattottiLaura GiordanoMats JerkemanTom van MeertenKatarzyna KrawczykFilipa MoitaDario MarinoSimone FerreroMichał SzymczykIgor AurerTarec Christoffer El-GalalyAlice Di RoccoCarlo ViscoGiuseppe CarliIrene DefrancescoCarmelo Carlo-StellaMartin DreylingArmando SantoroLuca ArcainiAbstract. While classical nodal mantle cell lymphoma (cMCL) is often associated with involvement of multiple extranodal sites, isolated extranodal disease (ED) at the time of diagnosis is a rare event; data on the outcome of these forms are lacking. On behalf of the European MCL Network, we conducted a retrospective analysis on the clinical characteristics and outcomes of MCL presenting with isolated or predominant ED (MALT MCL). We collected data on 127 patients with MALT MCL diagnosed from 1998 to 2015: 78 patients (61%) were male with a median age of 65 years. The involved sites include: upper airways + Waldeyer ring (40; 32%), gastrointestinal tract (32; 25%), ocular adnexa (17; 13%), oral cavity and salivary glands (17; 13%) and others (13; 1%); 7 patients showed multiple extranodal sites. The median follow-up was 80 months (range: 6–182), 5-year progression-free survival (PFS) was 45% (95% CI: 35–54) and 5-year overall survival (OS) was 71% (95% CI: 62–79). In an explorative setting, we compared MALT MCL with a group of 128 cMCL patients: MALT MCL patients showed a significantly longer PFS and OS compared with nodal cMCL; with a median PFS of 4.5 years vs 2.8 years (p = 0.001) and median OS of 9.8 years vs 6.9 years (p = 0.018), respectively. Patients with MALT MCL at diagnosis showed a more favorable prognosis and indolent course than classical nodal type. This clinical variant of MCL should be acknowledged to avoid possible over-treatment.http://journals.lww.com/10.1097/HS9.0000000000000302 |
spellingShingle | Lucia Morello Sara Rattotti Laura Giordano Mats Jerkeman Tom van Meerten Katarzyna Krawczyk Filipa Moita Dario Marino Simone Ferrero Michał Szymczyk Igor Aurer Tarec Christoffer El-Galaly Alice Di Rocco Carlo Visco Giuseppe Carli Irene Defrancesco Carmelo Carlo-Stella Martin Dreyling Armando Santoro Luca Arcaini Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study HemaSphere |
title | Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study |
title_full | Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study |
title_fullStr | Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study |
title_full_unstemmed | Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study |
title_short | Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study |
title_sort | mantle cell lymphoma of mucosa associated lymphoid tissue a european mantle cell lymphoma network study |
url | http://journals.lww.com/10.1097/HS9.0000000000000302 |
work_keys_str_mv | AT luciamorello mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT sararattotti mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT lauragiordano mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT matsjerkeman mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT tomvanmeerten mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT katarzynakrawczyk mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT filipamoita mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT dariomarino mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT simoneferrero mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT michałszymczyk mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT igoraurer mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT tarecchristofferelgalaly mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT alicedirocco mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT carlovisco mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT giuseppecarli mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT irenedefrancesco mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT carmelocarlostella mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT martindreyling mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT armandosantoro mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy AT lucaarcaini mantlecelllymphomaofmucosaassociatedlymphoidtissueaeuropeanmantlecelllymphomanetworkstudy |